Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis

Journal of Microbiology

Volumn 49, Issue 3, 2011, Pages 448-454

  Cai, Tommaso ^a   Mazzoli, Sandra ^b   Meacci, Francesca ^b   Boddi, Vieri ^c   Mondaini, Nicola ^c   Malossini, Gianni ^a   Bartoletti, Riccardo ^c  

^a SANTA CHIARA HOSPITAL   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

antibacterial agents; antibiotic susceptibility; bacterial prostatitis; Gram negative; Gram positive

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; OFLOXACIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROSTATITIS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PROSTATITIS; YOUNG ADULT;

BACILLI (CLASS); BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA;

EID: 79959724708     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: 10.1007/s12275-011-0391-z     Document Type: Article

References (28)

1. Arslan, H., O. K. Azap, O. Ergönül, and F. Timurkaynak. 2005. Urinary Tract Infection Study Group. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J. Antimicrob. Chemother. 56, 914-918.
2. Bundrick, W., S. P. Heron, P. Ray, W. M. Schiff, A. M. Tennenberg, B. A. Wiesinger, P. A. Wright, S. C. Wu, N. Zadeikis, and J. B. Kahn. 2003. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. Urology 62, 537-541.
3. Drusano, G. L., S. L. Preston, M. van Guilder, D. North, M. Gombert, M. Oefelein, L. Boccumini, B. Weisinger, M. Corrado, and J. Kahn. 2000. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrob. Agents Chemother. 44, 2046-2051.
4. Ena, J., F. Arjona, C. Martínez-Peinado, M. M. López-Perezagua, and C. Amador. 2006. Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 68, 1169-1174.
5. Fowler, J. E. Jr. 2002. Antimicrobial therapy for bacterial and nonbacterial prostatitis. Urology 60, 24-26.
6. Giubilei, G., N. Mondaini, A. Crisci, A. Raugei, G. Lombardi, F. Travaglini, G. Del Popolo, and R. Bartoletti. 2005. The Italian version of the National Institutes of Health chronic prostatitis symptom index. Eur. Urol. 47, 805-811.
7. Krieger, J. N. 2004. Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia. Minerva Urol. Nefrol. 56, 99-107.
8. Krieger, J. N., S. W. Lee, J. Jeon, P. Y. Cheah, M. L. Liong, and D. E. Riley. 2008. Epidemiology of prostatitis. Int. J. Antimicrob. Agents 31, 85-90.
9. Krieger, J. N., L. Nyberg, Jr., and J. C. Nickel. 1999. NIH consensus definition and classification of prostatitis. JAMA 282, 236-237.
10. Krieger, J. N. and D. E. Riley. 2004. Chronic prostatitis: Charlottesville to Seattle. J. Urol. 172, 2557-2560.
11. Krieger, J. N., D. E. Riley, P. Y. Cheah, M. L. Liong, and K. H. Yuen. 2003. Epidemiology of prostatitis: new evidence for a world-wide problem. World J. Urol. 21, 70-74.
12. Mazzoli, S. 2007. Conventional bacteriology in prostatitis patients: microbiological bias, problems and epidemiology on 1686 microbial isolates. Arch. Ital. Urol. Androl. 79, 71-75.
13. Mazzoli, S. 2010. Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications. FEMS Immunol. Med. Microbiol. Article in press.
14. Mazzoli, S., T. Cai, V. Rupealta, A. Gavazzi, R. C. Pagliai, N. Mondaini, and R. Bartoletti. 2007. Interleukin 8 and anti-chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection. Eur. Urol. 51, 1385-1393.
15. McNaughton-Collins, M., G. F. Joyce, T. Wise, and M. A. Pontari. 2007. Prostatitis. In M. S. Litwin and C. S. Saigal (eds.). Urologic Diseases in America. US Department of Health and Human Services, Public Health Taylor et al. p. 6 Am J Med. Author manuscript; available in PMC 2009 May 1. NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript Service, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. NIH Publication No. 07-5512. US Government Publishing Office, Washington, DC, USA.
16. Motrich, R. D., C. Cuffini, J. P. Oberti, M. Maccioni, and V. E. Rivero. 2006. Chlamydia trachomatis occurrence and its impact on sperm quality in chronic prostatitis patients. J. Infect. 53, 175-183.
17. Murphy, A. B., A. Macejko, A. Taylor, and R. B. Nadler. 2009. Chronic prostatitis: management strategies. Drugs 69, 71-84.
18. Naber, K. G. 2008. Management of bacterial prostatitis: what's new? BJU Int. 101, 7-10.
19. Naber, K. G., B. Bergman, M. C. Bishop, T. E. Bjerklund-Johansen, H. Botto, B. Lobel, F. Jinenez Cruz, F. P. Selvaggi, and Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). 2001. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur. Urol. 40, 576-588.
20. Nickel, J. C., R. B. Alexander, A. J. Schaeffer, J. R. Landis, J. S. Knauss, and K. J. Propert. 2003. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J. Urol. 170, 818-822.
21. Nickel, J. C. and J. Xiang. 2008. Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis. J. Urol. 179, 1391-1395.
22. Potts, J. and R. E. Payne. 2007. Prostatitis: Infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key. Cleve. Clin. J. Med. 74, 63-71.
23. Schaeffer, A. J. 2006. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N. Engl. J. Med. 355, 1690-1698.
24. Türk, S., P. Korrovits, M. Punab, and R. Mändar. 2007. Coryneform bacteria in semen of chronic prostatitis patients. Int. J. Androl. 30, 123-128.
25. Wagenlehner, F. M., T. Diemer, K. G. Naber, and W. Weidner. 2008a. Chronic bacterial prostatitis (NIH type II): diagnosis, therapy and influence on the fertility status. Andrologia 40, 100-104.
26. Wagenlehner, F. M., A. H. Niemetz, W. Weidner, and K. G. Naber. 2008b. Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005. Int. J. Antimicrob. Agents 31, 25-34.
27. Walz, J., P. Perrotte, G. Hutterer, N. Suardi, C. Jeldres, F. Bénard, L. Valiquette, and P. I. Karakiewicz. 2007. Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. BJU Int. 100, 1307-1311.
28. Weidner, W., T. Diemer, P. Huwe, H. Rainer, and M. Ludwig. 2002. The role of Chlamydia trachomatis in prostatitis. Int. J. Antimicrob. Agents 19, 466-470.